Absence of Transplacental Passage of Pentosan Polysulfate During Mid Trimester of Pregnancy

Summary

Eight women who were going to have an abortion between the 18th and 23rd week of gestation for chromosomal abnormalities or haemoglobinopathies received intravenously 50 mg of pentosan polysulfate (PSP). Maternal results of haemostasis prior and after the injection of the drug were compared. Fetal coagulation parameters were tested on samples obtained by direct puncture of the umbilical cord under ultrasound guidance, 30 min after injection. Results were compared to those of normal fetuses at the same stage of gestation, obtained in the same conditions. In mothers’ plasma, 30 min after injection, APTT was prolonged, factor Xa generation was markedly impaired, and factor V level was deeply decreased. By contrast, no modifications of these parameters were observed in fetal plasma, 30 min after the injection of PSP to their related mothers when compared to control fetuses. Thus the absence of biological modifications induced by PSP injection could demonstrate that this drug does not cross through the placenta.

Key words

Fetal coagulation - Pentosan polysulfate - Pharmacology

• References

• 1 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Haemostas 1965; 13: 516-530
• 2 Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound. A study of 606 consecutive cases. Am J Obstet Gynecol 1985; 153: 655-660
• 3 Desmonts G, Daffos F, Forestier F, Thulliez P, Capella-Pavlovsky M, Chartier M. Prenatal diagnosis of congenital toxoplasmosis. Lancet 1985; 1: 500-503
• 4 Forestier F, Daffos F, Galacteros F, Bardakjian J, Rainaut M, Beuzard Y. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res 1986; 20: 342-347
• 5 Josso F, Prou-Wartelle O. Tests de l’hémostase. In: Techniques en hématologie Alagille D, Colombani J, Dausset J, Fine JM, Josso F. (eds) Flammarion; Paris: 1972. pp 141-191
• 6 Aiach M, Michael A, Balian JL, Lefevre M, Woler M, Fourtillon J. A new Low Molecular Weight Heparin derivative. In vitro and in vivo studies. Thromb Res 1983; 31: 611-621
• 7 Fischer AM, Barrowcliffe TW, Thomas DP. A comparison of pentosan polysulphate (SP 54) and heparin. I: mechanism of action on blood coagulation. Thromb Haemostas 1982; 47: 104-108
• 8 Hellgren M, Tengborn L, Abildgaard U. Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin. Gynecol Obstet 1982; 14: 127-141
• 9 Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. In: Clinics in Haematology Prentice CR M. (ed) Saunders; London: 1981. 10: pp 369-390
• 10 Soria C, Soria J, Ryckewaert JJ, Holmer E, Caen J. Anticoagulant activities of a pentosan polysulphate: comparison with standard heparin and a fraction of low molecular weight heparin. Thrombos Res 1980; 19: 455-463
• 11 Vinazzer H, Hass S, Stemberger A. Influence on the clotting mechanism of sodium pentosan polysulphate (SP 54) in comparison to commercial beef lung sodium heparin. Thromb Res 1980; 20: 57-68
• 12 Fischer AM, Dautzenberg MD, Aurousseau MH, Beguin S, Goudemand J, Hemker HC. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients. Thromb Res 1985; 37: 295-307
• 13 Forestier F, Daffos F, Rainaut M, Solé Y, Amiral Y. Vitamin K dependent proteins in fetal haemostasis at mid trimester of pregnancy. Thromb Haemostas 1985; 53: 401-403
• 14 Forestier F, Daffos F, Solé Y, Rainaut M. Prenatal diagnosis of haemophilia by fetal blood sampling under ultrasound guidance. Haemostasis 1986; 16: 346-351
• 15 Fischer AM, Merton RE, Marsh NA, Williams S, Gaffney PJ, Barrowcliffe TW, Thomas DP. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection. Thromb Haemostas 1982; 47: 109-113
• 16 MacGregor IR, Dawes J, Pepper DS, Prowse CV, Stocks J. Metabolism of sodium pentosan polysulphate in man measured by a new competitive binding assay for sulphated polysaccharides - Comparison with effects upon anticoagulant activity, lipolysis and platelet granule proteins. Thromb Haemostas 1985; 53: 411-414
• 17 Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy. Study by direct foetal blood sampling under ultrasound. Thromb Res 1984; 34: 557-560
• 18 Forestier F, Daffos F, Rainaut M. Pre-eclampsia and prostaglandins. Lancet 1985; 1: 268